Mologen AG Out-Licenses Marketing Rights For India And Receives Further Upfront Payment

December 29, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

The Berlin-based biotechnology company MOLOGEN AG announced today that licensing and marketing rights for MOLOGEN´s innovative cell-based gene-therapy for India were granted to ONCO Life Sciences, Pvt., Ltd.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Europe